Index DJIA, S&P 500
P/E 30.26
EPS (ttm) 16.37
Insider Own 0.19%
Shs Outstand 924.00M
Perf Week -1.15%
Market Cap 455.76B
Forward P/E 15.97
EPS next Y 31.01
Insider Trans -5.26%
Shs Float 918.38M
Perf Month 0.46%
Income 15.36B
PEG 2.34
EPS next Q 6.75
Inst Own 90.34%
Short Float 0.86%
Perf Quarter -1.56%
Sales 379.49B
P/S 1.20
EPS this Y 10.39%
Inst Trans -0.70%
Short Ratio 1.74
Perf Half Y -6.57%
Book/sh 96.06
P/B 5.16
EPS next Y 11.84%
ROA 5.41%
Short Interest 7.89M
Perf Year 2.57%
Cash/sh -
P/C -
EPS next 5Y 12.93%
ROE 26.88%
52W Range 436.38 - 554.70
Perf YTD -5.91%
Dividend Est. 7.79 (1.57%)
P/FCF 43.34
EPS past 5Y 14.37%
ROI 10.18%
52W High -10.70%
Beta 0.55
Dividend TTM 7.52 (1.52%)
Quick Ratio -
Sales past 5Y 10.48%
Gross Margin -
52W Low 13.51%
ATR (14) 11.20
Dividend Ex-Date Mar 08, 2024
Current Ratio 0.85
EPS Y/Y TTM 12.26%
Oper. Margin 8.49%
RSI (14) 58.96
Volatility 1.71% 1.94%
Employees 440000
Debt/Eq 0.83
Sales Y/Y TTM 12.96%
Profit Margin 4.05%
Recom 1.38
Target Price 568.00
Option/Short Yes / Yes
LT Debt/Eq 0.72
EPS Q/Q -125.68%
Payout 30.55%
Rel Volume 0.60
Prev Close 493.86
Sales Surprise 0.57%
EPS Surprise 4.48%
Sales Q/Q 8.56%
Earnings Apr 16 BMO
Avg Volume 4.55M
Price 495.35
SMA20 5.32%
SMA50 1.76%
SMA200 -2.61%
Trades
Volume 2,726,577
Change 0.30%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-04-24 Upgrade
HSBC Securities
Reduce → Hold
$460
Mar-06-24 Initiated
Barclays
Overweight
$551
Dec-18-23 Downgrade
HSBC Securities
Hold → Reduce
$550 → $480
Oct-16-23 Upgrade
UBS
Neutral → Buy
$520 → $640
Sep-06-23 Initiated
HSBC Securities
Hold
$540
Jul-19-23 Reiterated
UBS
Neutral
$510 → $520
Jul-18-23 Upgrade
Bernstein
Mkt Perform → Outperform
$595 → $603
Jul-17-23 Reiterated
TD Cowen
Outperform
$562 → $555
Jul-17-23 Reiterated
RBC Capital Mkts
Outperform
$592 → $572
Jul-17-23 Reiterated
JP Morgan
Overweight
$527 → $532
May-26-23 Initiated
Piper Sandler
Overweight
$580
Apr-21-23 Initiated
Cantor Fitzgerald
Overweight
$591
Apr-05-23 Upgrade
Raymond James
Outperform → Strong Buy
$615 → $630
Nov-23-22 Resumed
Morgan Stanley
Overweight
$587
Nov-21-22 Downgrade
Raymond James
Strong Buy → Outperform
$615
Jun-17-22 Initiated
Loop Capital
Buy
$575
May-27-22 Downgrade
Bernstein
Outperform → Mkt Perform
$561
Dec-14-21 Initiated
Goldman
Buy
$535
Sep-27-21 Initiated
SVB Leerink
Outperform
$480
Sep-10-21 Initiated
Cowen
Outperform
$478
Show Previous Ratings
Apr-27-24 11:10AM
09:15AM
09:00AM
08:54AM
08:49AM
08:45AM
Loading…
08:45AM
Apr-25-24 10:10AM
Apr-24-24 02:46PM
(The Wall Street Journal)
04:01AM
Apr-23-24 03:56PM
01:51PM
01:37PM
12:59PM
12:18PM
12:00PM
11:40AM
Loading…
11:40AM
(Associated Press Finance)
10:54AM
10:45AM
08:10AM
06:12AM
Apr-22-24 07:40PM
(The Wall Street Journal)
05:56PM
05:53PM
05:45PM
05:43PM
04:40PM
04:22PM
(Investor's Business Daily)
02:55PM
(The Wall Street Journal)
01:39PM
12:11PM
10:12AM
Loading…
10:12AM
09:55AM
09:00AM
07:29AM
07:19AM
07:00AM
(The Wall Street Journal)
06:54AM
Apr-20-24 09:16AM
Apr-19-24 04:45PM
03:45PM
07:45AM
Apr-18-24 04:26PM
01:10PM
(Investor's Business Daily)
12:56PM
10:45AM
(The Wall Street Journal)
10:00AM
09:49AM
09:41AM
06:17AM
Apr-17-24 02:06PM
11:28AM
09:53AM
08:34AM
08:00AM
03:01AM
Apr-16-24 06:31PM
06:25PM
(The Wall Street Journal)
05:50PM
04:49PM
(Investor's Business Daily)
04:20PM
04:20PM
03:36PM
(Investor's Business Daily)
03:23PM
02:44PM
02:15PM
02:15PM
(The Wall Street Journal)
02:08PM
(The Wall Street Journal)
02:02PM
01:54PM
(Investor's Business Daily)
01:47PM
(The Wall Street Journal)
01:25PM
12:37PM
(The Wall Street Journal)
12:30PM
12:19PM
(Associated Press Finance)
12:15PM
(The Wall Street Journal)
12:14PM
(Investor's Business Daily)
11:57AM
11:50AM
11:27AM
11:26AM
(The Wall Street Journal)
11:22AM
10:53AM
10:37AM
(Investor's Business Daily)
10:30AM
10:24AM
(The Wall Street Journal)
10:08AM
10:04AM
(The Wall Street Journal)
10:02AM
10:01AM
09:57AM
09:34AM
09:32AM
09:30AM
09:15AM
(Associated Press Finance)
08:54AM
08:44AM
08:30AM
(Investor's Business Daily)
08:08AM
07:49AM
07:31AM
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
McSweeney Erin EVP & Chief People Officer Mar 08 '24 Sale 483.48 1,236 597,582 9,364 Mar 12 04:16 PM ROOS THOMAS E Chief Accounting Officer Feb 23 '24 Sale 525.79 858 451,128 32,289 Feb 26 04:25 PM THOMPSON BRIAN R CEO, UnitedHealthcare Feb 16 '24 Option Exercise 255.22 82,348 21,016,460 72,806 Feb 20 04:10 PM THOMPSON BRIAN R CEO, UnitedHealthcare Feb 16 '24 Sale 521.00 28,943 15,079,303 25,543 Feb 20 04:10 PM HEMSLEY STEPHEN J Director Dec 05 '23 Option Exercise 108.97 66,081 7,200,847 701,609 Dec 07 04:22 PM HEMSLEY STEPHEN J Director Dec 05 '23 Sale 550.39 66,081 36,370,196 635,528 Dec 07 04:22 PM HEMSLEY STEPHEN J Director Oct 17 '23 Option Exercise 82.22 121,515 9,991,345 643,333 Oct 19 08:00 PM HEMSLEY STEPHEN J Director Oct 17 '23 Sale 540.58 121,515 65,688,591 521,818 Oct 19 08:00 PM McSweeney Erin EVP Chief People Officer Oct 16 '23 Option Exercise 302.20 4,498 1,359,296 13,716 Oct 18 05:39 PM McSweeney Erin EVP Chief People Officer Oct 16 '23 Sale 544.28 4,498 2,448,192 9,218 Oct 18 05:39 PM WITTY ANDREW CEO, UHG Jul 19 '23 Sale 506.19 4,000 2,024,760 78,573 Jul 21 04:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite